When compared to both HC and untreated patients, the differences in pSTAT5 levels (Δ pSTAT5 MFI) between FOXP3+ cells and the Tcon subset of CD4+ T-cells were higher, but not significantly different, in treated patients with CLL in general. The gene discussed is FOXP3; the disease is B-cell chronic lymphocytic leukemia.